Graph | Cluster | Transcripts | Mean logCPM | Classification | Smed/Human type | Human gene | Annotation |
---|---|---|---|---|---|---|---|
|
MligTC455_12446 | Mlig455_018810, Mlig455_018624 | -0.67 | Neural (non-ciliated); X2; Xins | CHRNA7; CHRNA10 | Mlig455_018810 {REF} {Length: 2717} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=141, Expect=2e-35]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=2e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=138, Expect=4e-34]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=2e-35]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=140, Expect=8e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=7e-35]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=1e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=4e-36]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=139, Expect=1e-34]} {RNA1509_9118} {RNA1310_84333} {RNA815_40596} {SMEDTYPE: Neural (non-ciliated) [dd_Smed_v6_8058_0_1, NA]} {SMEDTYPE: X2 [raj_facs_types]} Mlig455_018624 {REF} {Length: 3606} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=2e-35]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=142, Expect=2e-35]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=136, Expect=2e-33]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=3e-35]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=140, Expect=2e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=139, Expect=2e-34]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=2e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=3e-36]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=138, Expect=2e-34]} {RNA1509_9118} {RNA1310_65904} {RNA815_40596} {SMEDTYPE: Xins [raj_facs_types]} |